The world's first AI bioinformatician

Genie TechBio is developing an LLM-powered omics analysis software that operates entirely in natural language—no coding needed, just like working with human experts.

Biomedical research is transforming into a data-driven science, presenting a challenge for biologists lacking extensive data analysis training. Confronting this obstacle in our own research careers, we resolved to create Genie – an LLM-powered tool designed for Omics analysis operated fully in natural language. Now, researchers, irrespective of their bioinformatics expertise, can effortlessly analyze extensive datasets. Engage in a conversation with Genie, just as you would with a human bioinformatician, and let it do the heavy lifting while you focus on the science.

Our mission is crystal clear: accelerate biomedical research and empower scientists with newfound data analysis capabilities.

How it works

1. Upload dataset

Users submit their dataset and provide details about the experiment in natural language.

2. Chat to instruct Genie

Genie offers recommendations for analysis pipelines, parameters, and underlying assumptions, after which the user confirms the proposed analysis for execution.

3. Get results

Genie executes it and providing output to the user. The user may request clarification or submit additional queries for further analysis

Do you take or store users' data?

No, we do not take or store users' data. We understand and respect the proprietary nature of data from companies and researchers. Your data remains fully under your control, ensuring confidentiality and privacy.

What technology powers Genie?

Genie harnesses the power of fine-tuned LLMs to bridge the gap between complex biological data analysis and user input. The magic lies in how the LLMs communicate nuanced tasks, while our hard-coded backend pipelines ensure robust and reproducible results.

What types of data can Genie analyze?

Currently, Genie supports bulk and single-cell transcriptomics analyses. Our team is actively working to expand into other omics areas. If you have specific bioinformatics analyses at your lab or company beyond transcriptomics, we'd love to hear about it. Please reach out to our team to discuss your needs!

Can Genie be customized for specific research needs?

Yes, Genie can be tailored to meet specific research requirements. If you have unique needs, our team can work with you to adapt the platform and ensure it fits your project.

Team

Iris Lam

During her PhD in Immunology, Iris frequently encountered delays in her research due to the shortage of bioinformaticians, a problem that caused significant frustration. Determined to find a solution, she turned to AI to address this critical bottleneck. At Genie, Iris is dedicated to communicating this vision, securing the necessary resources to build Genie, and encouraging adoption among researchers and biotech companies. If you're a researcher or biotech company interested in trying Genie, or an investor inspired to support this mission, Iris would love to connect with you.

Georg Basler, PhD

Georg is a Senior Bioinformatics Consultant and Software Engineer with over 15 years of experience providing bioinformatics services to more than 20 international startups and biotech companies. He holds a PhD in Bioinformatics and has held postdoctoral positions at UC Berkeley, Lawrence Berkeley National Laboratory, and the Max Planck Society. At Genie, Georg is committed to developing the software into a tool that can effectively replace his role as a bioinformatician. If you’re a researcher with a specific problem you'd like Genie to solve, Georg is the person to talk to.

Allysson Allan, PhD

Allysson is a Visiting Professor in Translational Medicine with over 10 years of experience in bioinformatics and data science. He previously served as Principal at the AI Lab of Pague Menos, Brazil's second-largest pharmacy chain, and has held postdoctoral roles as a Bioinformatics Scientist and Manager, boasting 20+ peer-reviewed publications. Allysson is the tech engine behind Genie’s development. He’s always excited to connect with fellow AI experts and explore new ideas.

Coaborate with us

In our early development phase, we're keen to hear from researchers interested in shaping Genie and investors excited about our vision. Get in touch, and let's start a conversation that could shape the future of bioinformatics together.

© 2024 Genie TechBio, Inc. All rights reserved.